Bryologyx
Clint is former Chairman and CEO of Abaxis, Inc., a company he led from a start-up to a publicly held company with over $220 million in revenues, to its acquisition in 2018 for $2 billion. He has had a more than 40 year-career in the healthcare industry. In 2007, he was named Forbes Entrepreneur of the Year.
This person is not in the org chart
This person is not in any offices
Bryologyx
BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies.